News

In this context, a study appearing in Frontiers of Medicine explores the potential of dronedarone, an FDA-approved drug, in inhibiting ESCC proliferation through the CDK4/CDK6-RB1 axis ...
Sekine and colleagues, therefore, investigated the effects of two small-molecule CDK inhibitors—the broad-spectrum CDK inhibitor alvocidib, and a novel, selective, CDK4 + CDK6 inhibitor—on ...